Description     Claims     Drawing  

WO2006066878A   [0006]  [0011] 
EP0352089A2   [0019] 
WO8803171A   [0019] 
EP0278112A2   [0019] 
WO0179271A   [0028] 
WO2005024044A   [0035] 
US20040087778A   [0038] 
WO2005001025A   [0038] 
WO2006000448A   [0038] 
WO2005063808A   [0038] 
WO2003076567A   [0038] 
WO2005000892A   [0038] 
WO2004101740A   [0038] 
US6403077B   [0038] 
EP258067A   [0061] 
EP07002903A   [0119] 
EP08707646A   [0119] 

Role of tissue factor in hemostasis, thrombosis, and vascular development   [0004] 
Defective thrombus formation in mice lacking factor XII   [0005] 
DX-88 and HAE: a developmental perspective   [0006] 
A mosquito salivary protein inhibits activation of the plasma contact system by binding to factor XII and high molecular weight kininogen   [0006] 
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial   [0008] 
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma   [0010] 
Hemostasis and Thrombosis. Basic principles & clinical practice   [0010] 
Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion   [0010] 
Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of FXII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction   [0010] 
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: A study of prevalence in 21 patients and review of the literature   [0010] 
John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study   [0010] 
Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families   [0010] 
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis   [0011] 
Infestin, a thrombin inhibitor present in Triatoma infestans midgut, a Chagas' disease vector: gene cloning, expression and characterization of the inhibitor   [0012] 
Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae)   [0012] 
Strategies to improve plasma half-life time of peptide and protein drugs   [0025] 
Structure and evolution of human alpha-fetoprotein deduced from partial sequence of cloned cDNA   [0035] 
Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family   [0035] 
Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family   [0035] 
Protein inhibitors of proteinases   [0041] 
Nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine   [0062] 
Isolation and characterization of mutants constitutive for expression of the fbp1 gene of Schizosaccharomyces pombe   [0062] 
The production of recombinant pharmaceutical proteins in plants   [0066] 
Transgenic milk as a method for the production of recombinant antibodies   [0067] 
Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits   [0067] 
Transgenesis using nuclear transfer in goats   [0067] 
Pharmaceutical Formulation Development of Peptides and Proteins   [0071] 
Handbook of Pharmaceutical Excipients   [0071] 
Are hemostasis and thrombosis two sides of the same coin?   [0080]